Sionna Therapeutics, Inc.
SION
$42.18
-$0.59-1.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -29.01% | -22.01% | -22.45% | -- | -- |
| Total Depreciation and Amortization | -2.87% | -3.14% | 0.00% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.92% | -2.94% | -33.47% | -- | -- |
| Change in Net Operating Assets | -18.70% | 13.76% | 125.42% | -- | -- |
| Cash from Operations | -28.53% | -25.59% | -26.81% | -- | -- |
| Capital Expenditure | -157.52% | -1,296.30% | -63.93% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 133.01% | 6.71% | 6.66% | -- | -- |
| Cash from Investing | 132.78% | 6.43% | 6.59% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.11% | 146,014.89% | 176,096.55% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 87.21% | -- | -34.05% | -- | -- |
| Cash from Financing | -97.39% | 14.94% | 12.35% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33,882.46% | 2,919.10% | 587.14% | -- | -- |